BridgeBio Oncology Therapeutics, Inc. (BBOT) — Working Capital to Net Assets Ratio
BridgeBio Oncology Therapeutics, Inc. (BBOT) has a Working Capital to Net Assets ratio of 95.0% as of December 2025. Working capital of $390.42 Million (current assets of $425.46 Million minus current liabilities of $35.04 Million) is measured against net assets of $411.10 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how leveraged is BridgeBio Oncology Therapeutics, Inc.'s balance sheet to measure how much of total assets are equity-financed.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
BridgeBio Oncology Therapeutics, Inc. Working Capital to Net Assets (2023–2025)
This chart shows how BridgeBio Oncology Therapeutics, Inc.'s Working Capital to Net Assets ratio has evolved across 3 annual periods from 2023 to 2025. As of December 2025, the ratio stands at 95.0%, reflecting working capital of $390.42 Million against net assets of $411.10 Million USD. Check how tangible is BridgeBio Oncology Therapeutics, Inc.'s equity to evaluate the tangible quality of the company's equity base.
Annual Working Capital to Net Assets for BridgeBio Oncology Therapeutics, Inc. (2023–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for BridgeBio Oncology Therapeutics, Inc. from 2023 to 2025, covering 3 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. For live market cap and the full company profile, see BridgeBio Oncology Therapeutics, Inc. market cap and net worth.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 95.0% | $390.42 Million | $411.10 Million | $425.46 Million | $35.04 Million | ▲ +94.0 pp |
| 2024 | 0.9% | $1.76 Million | $188.72 Million | $1.95 Million | $187.51K | ▲ +5570.5 pp |
| 2023 | -5569.6% | $3.54 Million | $-63.57K | $3.94 Million | $396.46K | — |